Latest news with #PAVM
Yahoo
6 days ago
- Business
- Yahoo
PAVmed subsidiary Veris Health partners with Ohio State University cancer center
PAVmed's (PAVM) majority-owned digital health subsidiary Veris Health has entered into a strategic partnership agreement with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, or OSUCCC – James, a National Cancer Institute-Designated Comprehensive Cancer Center. This agreement follows the successful completion of a pilot program which enrolled patients across several OSUCCC – James cancer care service lines on the Veris Cancer Care Platform. Veris and OSUCCC – James entered into a long-term, multi-project strategic partnership to utilize, and further the development and commercialization of the Veris Cancer Care Platform and its implantable physiologic monitor. The agreement includes expansion of commercial utilization of the platform across cancer care service lines; full electronic health record integration; initiation of a clinical registry of patients enrolled on the platform to be launched in the coming weeks; and launch of a clinical trial of patients receiving the implantable physiologic monitor, to be launched upon FDA clearance, expected next year. Cancer patients enrolled on the platform receive a VerisBox of Veris-branded connected health care devices which transmit physiologic data to the cloud-based clinician portal via embedded cellular connections. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PAVM: Disclaimer & DisclosureReport an Issue Lucid Diagnostics to join Russell 2000, Russell 3000 indexes PAVmed's Earnings Call: Optimism Amid Challenges PAVmed's Strategic Advancements and Growth Potential Drive Buy Rating Pavmed Inc. Reports Turnaround with Strong Q1 Earnings PAVmed Reports Q1 2025 Financial Results and Updates
Zawya
07-02-2025
- Health
- Zawya
Kenya Endorses Communique on Advancing Health Products Manufacturing
African Union (AU) Member States have endorsed a communiqué aimed at strengthening local manufacturing of vaccines, diagnostics, medicines, and other essential health products. Kenya's delegation, led by Principal Secretary for Medical Services Harry Kimtai, joined regional leaders in supporting key commitments to enhance health security and self-sufficiency across the continent. The communiqué highlights the upgrade of the Partnerships for African Vaccine Manufacturing (PAVM) to the Platform for Harmonized African Health Manufacturing (PHAHM) to drive self-reliance, the establishment of the African Pooled Procurement Mechanism (APPM) to improve affordability and access, and the strengthening of regulatory frameworks through the African Medicines Regulatory Harmonization (AMRH) and the African Medicines Agency (AMA). It also supports the Gavi African Vaccine Manufacturing Accelerator (AVMA), a $1.2 billion initiative to boost vaccine production, while promoting regional collaboration and financing mechanisms to sustain investments in Africa's health manufacturing sector. The forum urged AU Member States, regional economic communities, and global partners to prioritize procurement of African-made vaccines and health products to ensure demand certainty for local manufacturers. It also called for stronger commitments to talent development, financing, and coordinated procurement strategies to reduce import dependency. Kenya reaffirmed its commitment to advancing these initiatives, aligning with the AU's vision for a resilient and self-reliant health system across the continent. Distributed by APO Group on behalf of Ministry of Health, Kenya.
